Pew, Stakeholders Urge Senate to Address Drug Resistance When Renewing User Fee Agreement

Including the PASTEUR Act in the reauthorization would help to protect the public from superbugs

Pew Urges Senate to Address Drug Resistance

On March 15, The Pew Charitable Trusts joined more than 40 organizations in asking Congress to include the Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act in the reauthorization of the Prescription Drug User Fee Agreement (PDUFA). In a letter to the U.S. Senate Committee on Health, Education, Labor, and Pensions, the organizations—representing clinicians, scientists, patients, public health, animal agriculture, and the pharmaceutical and diagnostics industries—highlighted the growing threat of antibiotic-resistant bacteria and the urgent need for new antibiotics in addressing this public health issue as part of PDUFA legislation.

The bipartisan PASTEUR Act supports the development of new antibiotics and promotes their appropriate use. The bill was introduced by Representatives Mike Doyle (D-PA) and Drew Ferguson (R-GA) and Senators Michael Bennet (D-CO) and Todd Young (R-IN).

America’s Overdose Crisis
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Quick View

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.